BioVie Inc. Embedded Derivative, Fair Value of Embedded Derivative, Net
BioVie Inc. (BIVI) had Embedded Derivative, Fair Value of Embedded Derivative, Net of -$1.48 million as of 2022-03-31, per its 10-Q filed 2022-05-11.
Discontinued › Notes
us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet · last filed 2022-05-11
- 2022-03-31: Embedded Derivative, Fair Value of Embedded Derivative, Net -$1.48M.
- 2021-12-31: Embedded Derivative, Fair Value of Embedded Derivative, Net -$1.22M.
| Period end | Embedded Derivative, Fair Value of Embedded Derivative, Net |
|---|---|
| 2022-03-31 | -$1.48M 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$1.22M 10-Q · filed 2022-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |